Skip to main content
. 2020 Nov 24;9(2):139–145. doi: 10.1093/gastro/goaa084

Table 1.

Demographics and clinicopathologic features in 454 patients with distal pancreatic adenocarcinoma

Feature No. of patients (%)
Age, years (mean ± SD) 67.1 ± 10.1
Sex
 Female 243 (53.5)
 Male 211 (46.5)
Type of cancer
 Invasive IPMN 78 (17.2)
 Non-IPMN-associated carcinoma 376 (82.8)
Tumor location
 Tail 229 (50.4)
 Body 146 (32.2)
 Tail/body 73 (16.1)
 Tail/body/head 6 (1.3)
Histopathologic differentiation
 Well 41 (9.0)
 Moderate 271 (59.7)
 Poor 128 (28.2)
 Unknown 14 (3.1)
T category, n (%)
 T1 76 (16.7)
 T2 202 (44.5)
 T3 166 (36.6)
 Tx 10 (2.2%)
Lymph-node metastasis
 Positive 238 (52.4)
 Negative 216 (47.6)
Post-operative adjuvant chemotherapy
 Yes 84 (18.5)
 No 303 (66.7)
 Unknown 67 (14.8)
Pathologic SA invasion
 Present 25 (5.5)
 Absent 249 (54.8)
 Not reported 180 (39.6)
Pathologic SV invasion
 Present 53 (11.7)
 Absent 220 (48.5)
 Not reported 181 (39.9)
Splenic parenchymal invasion
 Present 25 (5.5)
 Absent 425 (93.6)
 Not reported 4 (0.9)
Radiographic SA invasion
 Present 73 (16.1)
 Absent 242 (53.3)
 Not examined 139 (30.6)
Radiographic SV invasion
 Present 93 (20.5)
 Absent 228 (50.2)
 Not examined 133 (29.3)

IPMN, intraductal papillary mucosal neoplasm; SA, splenic artery; SV, splenic vein; Tx, pathologic tumor stage not specified.